SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after reports surfaced of a potential partnership with Novo Nordisk to distribute GLP-1 obesity drugs, signaling an end to their prior legal dispute. This development has ignited fervent community discussion about a massive short squeeze due to the stock's high short interest and its strengthened position in the digital health market.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community celebrates the imminent departure of a prominent FDA official, widely seen as a significant barrier to the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. This development, coupled with high anticipation for a late-breaking Phase 3 data presentation at a major medical conference, is fueling intense bullish sentiment and expectations for a rapid regulatory decision.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending after forming a partnership with Hims & Hers to distribute its obesity drugs, ending a prior feud and surprising the community. This, alongside reports of rapidly accelerating oral Wegovy prescriptions and an FDA crackdown on compounded GLP-1s, is driving discussion that the stock is oversold despite ongoing competitive dynamics with Eli Lilly.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure NV is surging on high volume as the community speculates a massive short squeeze and a bullish sentiment shift, following news of a key FDA official's impending departure, which is seen as favorable for gene therapies like QURE's Huntington's therapy. This is amplified by discussions of a newly clarified, less burdensome regulatory path for their lead asset and a technical rebound from oversold conditions.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara is trending following the FDA's Day 74 Letter confirming MOLBREEVI's Biologics License Application is under full review with a PDUFA target action date of August 22, 2026, and no advisory committee meeting planned. The community sees this as a positive step towards Molbreevi becoming a first-in-class therapy for autoimmune PAP, fueling optimism around its market potential and future valuation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as escalating U.S.-Iran tensions have severely disrupted oil tanker traffic through the Strait of Hormuz, propelling crude prices higher. The community is split between calls for further parabolic gains to $150-$200 due to broken supply chains and warnings of a manipulated "blow-off top" and imminent correction, with broader concerns about inflation.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

VOO is trending amidst heightened market uncertainty driven by Federal Reserve policy, geopolitical developments, and ongoing debates about the sustainability of valuations in the tech sector. Despite some community calls for a significant correction, many investors continue to favor VOO for its broad market exposure and long-term stability.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is driving intense conversation, fueled by fresh reports of potential Nvidia chip exports to China and strong AI demand outlooks from semiconductor giants, though community sentiment is sharply divided. While many view the sector as an unstoppable "infinite money glitch" in the AI boom, others warn of an impending "bubble" due to stretched valuations and recent underperformance against software ETFs.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as its inclusion in the S&P 500 and a significant investment from NVIDIA for optical technology in AI infrastructure drive conversation, fueling an active debate among investors regarding its current valuation and the future adoption of photonics versus copper solutions.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as its CEO hints at "curative outcomes" for AML, sparking community excitement about groundbreaking efficacy and a potential short squeeze, with further anticipation from an ongoing oncology summit. The prolonged duration of its pivotal REGAL trial, indicating patients are living longer than expected, reinforces investor belief in the drug's transformative potential beyond disease management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jack Henry (JKHY) Down 3.1% Since Last Earnings Report: Can It Rebound?

Jack Henry (JKHY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Procare Solutions Releases 2026 Child Care Business Trends Report

Procare Solutions Releases 2026 Child Care Business Trends Report Procare Solutions Releases 2026 Child Care Business Trends Report PR Newswire DENVER, March 4, 2026 DENVER, March 4, 2026...

Illumia Unveils New Brand Identity at Momentum Conference, Announces 2026 Distinction Award Winners

Illumia, an award-winning leader in innovative higher education, healthcare, senior living, and corporate technology, revealed its new brand identity at Momentum 26, its annual user conference. The...

NZS Capital LLC Buys 73,113 Shares of Roper Technologies, Inc. $ROP

NZS Capital LLC lifted its stake in shares of Roper Technologies, Inc. (NASDAQ:ROP - Free Report) by 50.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

Elo Mutual Pension Insurance Co Purchases 3,829 Shares of Roper Technologies, Inc. $ROP

Elo Mutual Pension Insurance Co increased its position in Roper Technologies, Inc. (NASDAQ:ROP - Free Report) by 33.5% in the third quarter, according to the company in its most recent filing with...

Roper Technologies, Inc. (NASDAQ:ROP) Sees Large Increase in Short Interest

Roper Technologies, Inc. (NASDAQ:ROP - Get Free Report) saw a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 2,977,226 shares, a...

Erste Asset Management GmbH Sells 3,032 Shares of Roper Technologies, Inc. $ROP

Erste Asset Management GmbH decreased its stake in Roper Technologies, Inc. (NASDAQ:ROP - Free Report) by 63.3% in the 3rd quarter, according to the company in its most recent 13F filing with the...

Roper Technologies, Inc. (NASDAQ:ROP) Receives Average Recommendation of "Hold" from Brokerages

Shares of Roper Technologies, Inc. (NASDAQ:ROP - Get Free Report) have received a consensus rating of "Hold" from the eighteen ratings firms that are covering the firm, Marketbeat.com reports. Three...

Roper Technologies, Inc. $ROP Shares Acquired by Rafferty Asset Management LLC

Rafferty Asset Management LLC grew its holdings in Roper Technologies, Inc. (NASDAQ:ROP - Free Report) by 8.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Roper Technologies, Inc. $ROP Stock Position Raised by Handelsbanken Fonder AB

Handelsbanken Fonder AB increased its position in Roper Technologies, Inc. (NASDAQ:ROP - Free Report) by 11.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm...

Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. It operates through the following segments: Application Software, Network Software, and Technology Enabled Products. The Application Software segment includes Aderant, CBORD/Horizon, CliniSys, Data Innovations, Deltek, Frontline Education, IntelliTrans, PowerPlan, Strata, and Vertafore. The Network Software segment is composed of ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment refers to CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. The company was founded by George D. Roper in 1890 and is headquartered in Sarasota, FL.

ROP
Roper Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ROP News

ROPRoper Technologies Inc